Evidence map›Paper›PMID 23321913›Full record

ReviewJapanese journal of ophthalmology2013

Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Chihiro Mayama, Makoto Araie

Abstract readReview
PubMed Publisher
In one paragraph

Review in Japanese journal of ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Central macular OCTA parameters in glaucoma.The British journal of ophthalmology · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Pharmacotherapy of glaucoma.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2015
    Review
  13. Observational
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chihiro MayamaDepartment of Ophthalmology, The University of Tokyo School of Medicine, Tokyo, Japan.
Makoto Araie
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An association between glaucoma development or progression and compromised ocular blood flow has been postulated as a result of population-based studies and prospective cohort studies. Blood flow in the optic nerve head (ONH) is of primary importance in the pathogenesis of glaucoma. The potential to modify the blood flow in the ONH and its related structures has been reported in various agents, including topical antiglaucoma drugs and systemic drugs such as calcium channel antagonists, which are reviewed in this manuscript. Clinical implications of the improvement in ocular blood flow on the treatment of glaucomatous optic neuropathy require further investigation.

Indexed as

Adrenergic alpha-AgonistsAdrenergic alpha-AntagonistsAdrenergic beta-AntagonistsAntihypertensive AgentsBlood Flow VelocityCarbonic Anhydrase InhibitorsCholinergic AgonistsGlaucomaHumansIntraocular PressureOptic DiskOptic Nerve DiseasesProstaglandins, SyntheticRegional Blood FlowAdrenergic alpha-AgonistsAdrenergic alpha-AntagonistsAdrenergic beta-AntagonistsAntihypertensive AgentsCarbonic Anhydrase InhibitorsCholinergic AgonistsProstaglandins, Synthetic

Identifiers

PMID23321913
OpenAlexW2014139908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.